Legis Daily

Eliminating Opioid Related Infectious Diseases Act of 2018

USA115th CongressHR-5353| House 
| Updated: 6/13/2018
Leonard Lance

Leonard Lance

Republican Representative

New Jersey

Cosponsors (14)
Joseph P. Kennedy (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)Peter T. King (Republican)Marsha Blackburn (Republican)Greg Walden (Republican)Michelle Lujan Grisham (Democratic)Rodney Davis (Republican)Doris O. Matsui (Democratic)Chris Collins (Republican)Anna G. Eshoo (Democratic)Yvette D. Clarke (Democratic)Joe Barton (Republican)Jaime Herrera Beutler (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Eliminating Opioid Related Infectious Diseases Act of 2018 This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention to expand its grant program for combating hepatitis C infections to include other infections associated with injection drug use.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 20, 2018
Introduced in House
Mar 20, 2018
Referred to the House Committee on Energy and Commerce.
Apr 25, 2018
Referred to the Subcommittee on Health.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
May 9, 2018
Committee Consideration and Mark-up Session Held.
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
Jun 12, 2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5059-5060)
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5353.
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5059)
Jun 12, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5059)
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • March 20, 2018
    Introduced in House


  • March 20, 2018
    Referred to the House Committee on Energy and Commerce.


  • April 25, 2018
    Referred to the Subcommittee on Health.


  • April 25, 2018
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • April 25, 2018
    Subcommittee Consideration and Mark-up Session Held.


  • May 9, 2018
    Committee Consideration and Mark-up Session Held.


  • May 9, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • June 12, 2018
    Mr. Walden moved to suspend the rules and pass the bill, as amended.


  • June 12, 2018
    Considered under suspension of the rules. (consideration: CR H5059-5060)


  • June 12, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 5353.


  • June 12, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5059)


  • June 12, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5059)


  • June 12, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 13, 2018
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • S 115-2579: A bill to amend the Public Health Service Act to reauthorize and expand a program of surveillance and education, carried out by the Centers of Disease Control and Prevention, regarding infections associated with injection drug use.
Digestive and metabolic diseasesDrug, alcohol, tobacco useDrug trafficking and controlled substancesHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHIV/AIDSIndian social and development programsInfectious and parasitic diseasesMedical educationMinority health

Eliminating Opioid Related Infectious Diseases Act of 2018

USA115th CongressHR-5353| House 
| Updated: 6/13/2018
Eliminating Opioid Related Infectious Diseases Act of 2018 This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention to expand its grant program for combating hepatitis C infections to include other infections associated with injection drug use.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 20, 2018
Introduced in House
Mar 20, 2018
Referred to the House Committee on Energy and Commerce.
Apr 25, 2018
Referred to the Subcommittee on Health.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
May 9, 2018
Committee Consideration and Mark-up Session Held.
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
Jun 12, 2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5059-5060)
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5353.
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5059)
Jun 12, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5059)
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • March 20, 2018
    Introduced in House


  • March 20, 2018
    Referred to the House Committee on Energy and Commerce.


  • April 25, 2018
    Referred to the Subcommittee on Health.


  • April 25, 2018
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • April 25, 2018
    Subcommittee Consideration and Mark-up Session Held.


  • May 9, 2018
    Committee Consideration and Mark-up Session Held.


  • May 9, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • June 12, 2018
    Mr. Walden moved to suspend the rules and pass the bill, as amended.


  • June 12, 2018
    Considered under suspension of the rules. (consideration: CR H5059-5060)


  • June 12, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 5353.


  • June 12, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5059)


  • June 12, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5059)


  • June 12, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 13, 2018
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Leonard Lance

Leonard Lance

Republican Representative

New Jersey

Cosponsors (14)
Joseph P. Kennedy (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)Peter T. King (Republican)Marsha Blackburn (Republican)Greg Walden (Republican)Michelle Lujan Grisham (Democratic)Rodney Davis (Republican)Doris O. Matsui (Democratic)Chris Collins (Republican)Anna G. Eshoo (Democratic)Yvette D. Clarke (Democratic)Joe Barton (Republican)Jaime Herrera Beutler (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • S 115-2579: A bill to amend the Public Health Service Act to reauthorize and expand a program of surveillance and education, carried out by the Centers of Disease Control and Prevention, regarding infections associated with injection drug use.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Digestive and metabolic diseasesDrug, alcohol, tobacco useDrug trafficking and controlled substancesHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHIV/AIDSIndian social and development programsInfectious and parasitic diseasesMedical educationMinority health